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Case Reportsalthough it is the best therapeutic strategy in an acute
setting.
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tion. J Vasc Surg. 2010;51:207-9.Uterine leiomyoma extension into right atrium: A case reportHua-shan Xu, MD,a Khan Mohammed Firoj, MM,a Kamran Yunus Inamdar, MM,b and
Wen-zeng Zhao, MM,a Zhengzhou and Urumchi, ChinaUterine leiomyoma is a common disease in women; how-
ever, intravenous leiomyomatosis of uterine origin extend-
ing via inferior vena cava (IVC) into the right side of the
heart, known as intracardiac leiomyomatosis (ICL), is a
rare condition. Because of rarity, ICL is occasionally
misdiagnosed as a right atrial myxoma and thrombus.
CASE REPORT
A 42-year-old married premenopausal woman complain-
ing of intermittent vaginal bleeding was referred to our
department for an intracardiac mass. She had a 1-month his-
tory of progressive breathlessness, fatigue on exercise, and
edema of her lower extremities. Her echocardiogram re-
vealed a large mass in the right atrium, and the mass
extended via the IVC far into the pelvic vein (Figure 1),
which was confirmed on magnetic resonance imaging
(Figure 2). Because of unfamiliarity to the disease, it was
diagnosed as right atrial myxoma, combined with long-
standing IVC thrombosis. Later, pelvic ultrasonography re-
vealed multiple leiomyomas of the uterus, which made the
attention toward the diagnosis of ICL.
The patient underwent a 2-stage surgery. In the first
stage (transatrial tumor resection), the operation was per-
formed under normal temperature with establishment ofcardiopulmonary bypass (CPB) by draining the blood
from a single superior vena cava and recirculating back
through the aortic root. The tumor mass was having a
tailed-like structure invaded into the IVC (Figure 3), which
was pulled out gently through the right atrial incision. Imme-
diately after pulling out the mass, the IVC cannula was
advanced into the IVC. The surgical views revealed that
the tumor within the vessel and heart had no stalk and had
well-demarcated borders with the wall of vessel and heart
(Figure 3). Subsequently, the pathological report also
confirmed uterine smooth muscle origin. So, oral tamoxifen
(10 mg/d, twice a day for 3 months) was administered. The
second-stage surgery (hysterectomy)was done 2weeks later
for removing multiple uterine leiomyomas. In the recent
3 years of follow-up, she had no symptoms.DISCUSSION
ICL is exceedingly rare. Most patients are usually pre-
menopausal (median age, 44 years). A review of the litera-
ture reveals that more than half of the women with ICL hadFIGURE 1. Apical 4-chamber view of echocardiography with a right
atrialmass.RV, Right ventricle; LV, left ventricle;RA, right atrium;M, mass.
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FIGURE 2. Magnetic resonance imaging showing extension of the tumor
mass via inferior vena cava to the heart.
FIGURE 3. Tumor specimen extracted from the right atrium (RA).
Case Reportsa history of hysterectomy. Imaging studies, such as ultraso-
nography, computed tomography, and magnetic resonance
imaging, are useful investigations. Because of its nonspe-
cific clinical presentation and rarity, ICL continues to be
misdiagnosed as either thrombus or myxoma. The presence
of a long, serpentine, and polypoidal mobile mass extending
from the inferior vena cava into the right atrium should raise
the suspicion of ICL.
Norris and Parmley1 proposed that the intravenous leio-
myomatosis and ICL have 2 different origins, one is from
uterine smooth muscle cells and the other is from the venous
vessel itself; however, since the advent of immunohisto-
chemical application on this disease, almost all cases had
an estrogenic receptor on the smooth muscle cell surface.
Uterine leiomyomatosis is a systemic leiomyoma that
metastasizes beyond the uterus. Many organs may be
involved; other reported organs are the ovarian tube, ovary,
peritoneum, spinal nerve, and even lungs. So, the principle
of surgery is to first remove the intracardiac mass to prevent
sudden death, and then to have a radical resection of the
involved organ to prevent recurrence. Two different opin-
ions concerned with surgery were adopted by surgeons.2-6
First, there was 1-stage surgery proposing concomitant tho-
racotomy and laparotomy. This adoption prevents recur-
rence, but obvious drawbacks of diffuse bleeding due to
the extensive pelvic exploration after anticoagulation for
CPB exist. So, we recommend 2-stage surgery. In the first
stage, the tumor should be removed from the right atrium
under CPB. The tumor coat is always smooth, so we infer
that it does not have enough adhesions for tearing the ves-
sels. The other problem is that the tumor may break at the
far end of the tail because its small feet taking root into a
small vein, which may result in recurrence. The seconde14 The Journal of Thoracic and Cardiovascular Surgstage of a laparotomy surgery can be performed 2 weeks
later when the systemic coagulation state and heart function
return to normal. This permits an extensive exploration and
resection of the involved organs without much worrying
about the disaster of bleeding. Theoretically, the second
surgery can be performed even earlier. The suitable interval
between 2 surgical procedures remains to be studied and
tried. We recommend shortening the interval, even though
the patient is almost recovered.
On chemotherapy, Lo and Lau7 recommend that tamox-
ifen can be administered in patients who failed to undergo
surgical treatment. Theoretically, the tumor cell can metas-
tasize anywhere via blood flow and a suitable hormone con-
centration can flourish its growth. So, we recommend
giving oral tamoxifen for at least 3 months postoperatively
for subsiding the possible micrometastatic focus. The dura-
tion of drug treatment and its efficacy still remain to be
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